Isis Pharmaceuticals (ISIS)

20.81 +0.35  +1.71%  May 21, 5:00PM
Add to Watchlists Create an Alert

Isis Pharmaceuticals Cash from Financing Quarterly:

9.05M for March 31, 2013
View Full Chart

Isis Pharmaceuticals Cash from Financing Quarterly Chart

    Isis Pharmaceuticals Historical Cash from Financing Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 9.05M
    Dec. 31, 2012 -1.151M
    Sept. 30, 2012 34.40M
    June 30, 2012 7.737M
    March 31, 2012 -1.853M
    Dec. 31, 2011 0.585M
    Sept. 30, 2011 -0.888M
    June 30, 2011 0.359M
    March 31, 2011 -0.728M
    Dec. 31, 2010 2.675M
    Sept. 30, 2010 -0.401M
    June 30, 2010 2.354M
    March 31, 2010 0.068M
    Dec. 31, 2009 2.538M
    Sept. 30, 2009 5.189M
    June 30, 2009 0.891M
    March 31, 2009 193.38M
    Dec. 31, 2008 9.318M
    Sept. 30, 2008 2.15M
    June 30, 2008 25.17M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
       
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro

    About Cash From Financing

    An item on a company's cash flow statement. Lists aggregate change in cash position resulting from financing activities. Includes the company's cash inflows and outflows from issuing cash dividends, issuing and selling stock, and adding or changing loans.
    Learn More

    Get data for

    ISIS Cash from Financing Quarterly Benchmarks

    Companies
    Aegerion Pharmaceuticals
    Sanofi
    Biogen Idec -238.42M

    ISIS Cash from Financing Quarterly Rankings

    Overall 89th percentile
    861 of 8002
    Sector 86th percentile
    93 of 684 in Healthcare
    Industry 81st percentile
    45 of 248 in Biotechnology

    ISIS Cash from Financing Quarterly Range, Past 5 Years

    Minimum -1.853M Mar 2012
    Maximum 193.38M Mar 2009
    Average 14.54M